{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:11:07Z","timestamp":1740147067724,"version":"3.37.3"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA195565"],"award-info":[{"award-number":["U01 CA195565"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA214057"],"award-info":[{"award-number":["R01 CA214057"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA214057"],"award-info":[{"award-number":["R01 CA214057"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Purpose<\/jats:title>\n<jats:p>Women with breast cancer (BC) are at high risk of developing cardiovascular disease (CVD). We examined adherence to CVD medications and their association with major CVD events over 14 years of follow-up in the Pathways Heart Study, a prospective study of 4,776 stage I-III BC patients diagnosed from 2005\u20132013.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Eligibility included being alive 6 months post-BC diagnosis, with dyslipidemia, hypertension, or diabetes at diagnosis along with \u22651 prior outpatient order or dispensing for a statin, anti-hypertensive, or diabetes medication, respectively, in the 30 months prior. Medication adherence was measured from pharmacy data to calculate cumulative average adherence (CAA). Incident heart failure (HF), ischemic heart disease (IHD), and stroke were determined via validated diagnosis and procedure codes. Working marginal structural models (MSM) fitted with inverse probability weighting evaluated the effect of adherence regimens on the hazards for each CVD event, while controlling for baseline and time-varying confounders. MSM parameterizations included: 1) CAA&lt;100% versus CAA = 100% (ref), 2) CAA&lt;80% versus CAA\u226580% (ref) and 3) CAA&lt;80% versus 80%\u2264CAA&lt;100% versus CAA = 100%.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Poor statin adherence (CAA&lt;80%) was associated with higher risk of composite CVD (HR = 2.54; 95% CI: 1.09, 5.94) versus CAA\u226580%. Poor statin adherence was also associated with a higher risk of stroke (HR = 8.13; 95% CI: 2.03, 32.51) but not risk of IHD and HF. Further, compared with perfect adherence (CAA = 100%), good adherence (80%\u2264CAA&lt;100%) was associated with lower risk (HR = 0.35; 95% CI: 0.13, 0.92) while poor adherence (CAA&lt;80%) was associated with higher risk of composite CVD (HR = 2.45; 95% CI: 1.05, 5.70). Levels of adherence to anti-hypertensives and diabetes medications had mixed or null associations with risk of CVD.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Maintaining good adherence (\u226580%) to statins after BC treatment is beneficial for cardiovascular health in patients with dyslipidemia. Future studies should determine factors associated with lower adherence to statins and ways to improve adherence.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0310531","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T17:24:02Z","timestamp":1726766642000},"page":"e0310531","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-3950","authenticated-orcid":true,"given":"Marilyn L.","family":"Kwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Izano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Iribarren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal S.","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Nguyen-Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecile A.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janise M.","family":"Roh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Rillamas-Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn L.","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence H.","family":"Kushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Greenlee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Neugebauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"issue":"23","key":"pone.0310531.ref001","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"PM Ho","year":"2009","journal-title":"Circulation"},{"issue":"38","key":"pone.0310531.ref002","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","author":"R Chowdhury","year":"2013","journal-title":"European Heart Journal"},{"issue":"4","key":"pone.0310531.ref003","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ahj.2007.12.011","article-title":"Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease","volume":"155","author":"PM Ho","year":"2008","journal-title":"Am Heart J"},{"issue":"2","key":"pone.0310531.ref004","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction","volume":"297","author":"JN Rasmussen","year":"2007","journal-title":"Jama"},{"issue":"1","key":"pone.0310531.ref005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10549-013-2424-2","article-title":"Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment","volume":"138","author":"GS Calip","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"pone.0310531.ref006","doi-asserted-by":"crossref","first-page":"e800","DOI":"10.1200\/JOP.2016.011742","article-title":"Nonadherence to Oral Medications for Chronic Conditions in Breast Cancer Survivors.","volume":"12","author":"J Yang","year":"2016","journal-title":"J Oncol Pract"},{"issue":"8","key":"pone.0310531.ref007","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2022.12138","article-title":"Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"328","author":"R Chou","year":"2022","journal-title":"JAMA"},{"issue":"8","key":"pone.0310531.ref008","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jama.2022.13044","article-title":"Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement","volume":"328","author":"Force UPST","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"pone.0310531.ref009","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MLR.0b013e3182881c8e","article-title":"Risk-adjusting hospital mortality using a comprehensive electronic record in an integrated health care delivery system.","volume":"51","author":"GJ Escobar","year":"2013","journal-title":"Med Care"},{"issue":"7","key":"pone.0310531.ref010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.2013.108769","article-title":"Improved blood pressure control associated with a large-scale hypertension program","volume":"310","author":"MG Jaffe","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"pone.0310531.ref011","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2337\/dc12-0722","article-title":"Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE).","volume":"36","author":"AJ Karter","year":"2013","journal-title":"Diabetes Care"},{"issue":"15","key":"pone.0310531.ref012","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1200\/JCO.21.01736","article-title":"Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study.","volume":"40","author":"H Greenlee","year":"2022","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"journal-title":"MSMstructure SAS macro","author":"TG Leong TK","key":"pone.0310531.ref013"},{"issue":"2","key":"pone.0310531.ref014","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jspi.2005.12.008","article-title":"Nonparametric causal effects based on marginal structural models","volume":"137","author":"R Neugebauer","year":"2007","journal-title":"Journal of Statistical Planning and Inference"},{"journal-title":"Marginal Structural Models","year":"1997","author":"JM Robins","key":"pone.0310531.ref015"},{"issue":"1\/2","key":"pone.0310531.ref016","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1005285815569","article-title":"Association, Causation, and Marginal Structural Models.","volume":"121","author":"JM Robins","year":"1999","journal-title":"Synthese"},{"key":"pone.0310531.ref017","first-page":"6","article-title":"Super learner.","author":"MJ van der Laan","year":"2007","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"437","key":"pone.0310531.ref018","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/01621459.1997.10473608","article-title":"Polychotomous Regression","volume":"92","author":"C Kooperberg","year":"1997","journal-title":"Journal of the American Statistical Association"},{"journal-title":"XGBoost: A Scalable Tree Boosting System","year":"2016","author":"T Chen","key":"pone.0310531.ref019"},{"author":"HT Chen T","key":"pone.0310531.ref020","article-title":"Extreme gradient boosting R package"},{"issue":"6","key":"pone.0310531.ref021","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"SR Cole","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"1","key":"pone.0310531.ref022","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/0962280210386207","article-title":"Diagnosing and responding to violations in the positivity assumption","volume":"21","author":"ML Petersen","year":"2012","journal-title":"Stat Methods Med Res"},{"journal-title":"Vaart AWvd. Asymptotic Statistics. Cambridge: Cambridge University Press","year":"1998","key":"pone.0310531.ref023"},{"issue":"2","key":"pone.0310531.ref024","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/bimj.201900041","article-title":"Estimating treatment effects with partially observed covariates using outcome regression with missing indicators.","volume":"62","author":"HA Blake","year":"2020","journal-title":"Biom J"},{"issue":"1","key":"pone.0310531.ref025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0962280208092345","article-title":"Observation plans in longitudinal studies with time-varying treatments","volume":"18","author":"MA Hern\u00e1n","year":"2009","journal-title":"Stat Methods Med Res"},{"journal-title":"Evaluation of adaptive treatment strategies in an observational study where time-varying covariates are not monitored systematically","year":"2018","author":"N Kreif","key":"pone.0310531.ref026"},{"issue":"1","key":"pone.0310531.ref027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: A review and a look forward","volume":"25","author":"EA Stuart","year":"2010","journal-title":"Stat Sci"},{"issue":"21","key":"pone.0310531.ref028","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1001\/archinte.166.21.2307","article-title":"Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials","volume":"166","author":"P Thavendiranathan","year":"2006","journal-title":"Arch Intern Med"},{"issue":"10285","key":"pone.0310531.ref029","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"pone.0310531.ref030","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jama.2011.250","article-title":"Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis","volume":"305","author":"AM Thompson","year":"2011","journal-title":"Jama"},{"issue":"9131","key":"pone.0310531.ref031","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"15","key":"pone.0310531.ref032","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"RR Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"pone.0310531.ref033","article-title":"Adherence to cardiovascular disease risk factor medications among patients with cancer: a systematic review.","author":"LL Zullig","year":"2022","journal-title":"J Cancer Surviv"},{"issue":"11","key":"pone.0310531.ref034","doi-asserted-by":"crossref","first-page":"e0260358","DOI":"10.1371\/journal.pone.0260358","article-title":"Providers\u2019 mediating role for medication adherence among cancer survivors","volume":"16","author":"JG Trogdon","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"pone.0310531.ref035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10549-016-4043-1","article-title":"Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors","volume":"161","author":"GS Calip","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"pone.0310531.ref036","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/pds.3971","article-title":"Effects of breast cancer on chronic disease medication adherence among older women","volume":"25","author":"ML Santorelli","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"pone.0310531.ref037","first-page":"794","article-title":"Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast","volume":"12","author":"MP Banegas","year":"2018","journal-title":"prostate"},{"issue":"1","key":"pone.0310531.ref038","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/pds.3660","article-title":"Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment","volume":"24","author":"GS Calip","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"pone.0310531.ref039","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/cncr.32690","article-title":"Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac events","volume":"126","author":"DL Hershman","year":"2020","journal-title":"Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0310531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T17:24:14Z","timestamp":1726766654000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0310531"}},"subtitle":[],"editor":[{"given":"Hope","family":"Onohuean","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0310531","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2024,9,19]]}}}